Home Other Building Blocks 66104-23-2
66104-23-2,MFCD00153859
Catalog No.:AA00F9ZN

66104-23-2 | Pergolide mesylate salt

This product is typically in stock,please click "Inquire" below or
contact us at [email protected] for pricing and availability information.
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00F9ZN
Chemical Name:
Pergolide mesylate salt
CAS Number:
66104-23-2
Molecular Formula:
C20H30N2O3S2
Molecular Weight:
410.5938
MDL Number:
MFCD00153859
SMILES:
CS(=O)(=O)O.CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3
Properties
Computed Properties
 
Complexity:
480  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
3  
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
4  

Literature

Title: The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline.

Journal: Sleep 20120801

Title: The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease.

Journal: Journal of physiology and biochemistry 20120301

Title: Valvular heart disease in patients exposed to pergolide: insights from the clinical presentation.

Journal: Pharmacoepidemiology and drug safety 20120301

Title: Continuous buccolingual masticatory dyskinesia in Parkinson's disease.

Journal: BMJ case reports 20120101

Title: Regression of cardiac valvulopathy related to ergot-derived dopamine agonists.

Journal: Cardiovascular therapeutics 20111201

Title: Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine.

Journal: Behavioural brain research 20110930

Title: Executive control in Parkinson's disease: effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance.

Journal: Neuroscience letters 20110815

Title: A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome.

Journal: Sleep medicine 20110501

Title: Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample.

Journal: Sleep medicine 20110501

Title: Equine pituitary pars intermedia dysfunction.

Journal: The Veterinary clinics of North America. Equine practice 20110401

Title: The impact in Japan of regulatory action on prescribing of dopamine receptor agonists: analysis of a claims database between 2005 and 2008.

Journal: Drug safety 20110401

Title: Effects of pergolide mesylate on transduction efficiency of PEP-1-catalase protein.

Journal: Biochemical and biophysical research communications 20110318

Title: Dopamine agonists for restless legs syndrome.

Journal: The Cochrane database of systematic reviews 20110316

Title: Dopaminergic stimulation enhances confidence and accuracy in seeing rapidly presented words.

Journal: Journal of vision 20110223

Title: Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson's disease patients.

Journal: Neuro endocrinology letters 20110101

Title: Echocardiography for the detection of valvulopathy associated with the use of ergot-derived dopamine agonists in patients with Parkinson's disease.

Journal: Internal medicine (Tokyo, Japan) 20110101

Title: [New drugs for horses and production animals in 2010].

Journal: Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere 20110101

Title: Juvenile hormone synthesis is stimulated by activation of dopamine D1-like receptors in Drosophila.

Journal: Doklady. Biochemistry and biophysics 20110101

Title: Multitemperature stability and degradation characteristics of pergolide mesylate oral liquid.

Journal: Journal of pharmacy practice 20101201

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Drug-induced valvulopathy: an update.

Journal: Toxicologic pathology 20101001

Title: Compulsive singing associated with a dopamine agonist in Parkinson disease.

Journal: Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 20100601

Title: Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100501

Title: Excessive daytime somnolence in spinocerebellar ataxia type 1.

Journal: Journal of the neurological sciences 20100315

Title: Treatment of hyperadrenocorticism in donkeys.

Journal: The Veterinary record 20100130

Title: Retroperitoneal fibrosis secondary to pergolide therapy.

Journal: Internal medicine (Tokyo, Japan) 20100101

Title: Single-dose oral pharmacokinetics of pergolide mesylate in healthy adult mares.

Journal: Veterinary therapeutics : research in applied veterinary medicine 20100101

Title: Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

Journal: Nature chemical biology 20091001

Title: Effects of pergolide mesilate on metallothionein mRNAs expression in a mouse model for Parkinson disease.

Journal: Biological & pharmaceutical bulletin 20091001

Title: Drug-induced fibrotic valvular heart disease.

Journal: Lancet (London, England) 20090815

Title: Primary gait ignition disorder: report of three cases.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20090801

Title: Rounded atelectasis and respiratory compromise secondary to pergolide use.

Journal: Respirology (Carlton, Vic.) 20090801

Title: The older Parkinson's disease drugs pergolide and cabergoline have been linked to heart problems. Are there any new Parkinson's drugs which are safer for patients with heart risks?

Journal: Heart advisor 20090801

Title: Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20090601

Title: Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study.

Journal: American journal of physiology. Heart and circulatory physiology 20090601

Title: Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease.

Journal: Clinical neurology and neurosurgery 20090501

Title: Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do.

Journal: Heart (British Cardiac Society) 20090401

Title: Supports compounding standards.

Journal: Journal of the American Veterinary Medical Association 20090401

Title: Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.

Journal: Internal medicine journal 20090401

Title: Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.

Journal: Neuropsychologia 20090401

Title: Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy.

Journal: Journal of neurology 20090301

Title: High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease.

Journal: Journal of neural transmission (Vienna, Austria : 1996) 20090201

Title: Effects of compounding and storage conditions on stability of pergolide mesylate.

Journal: Journal of the American Veterinary Medical Association 20090201

Title: [Impulse control disorder induced by the use of dopamine agonists].

Journal: Nederlands tijdschrift voor geneeskunde 20090117

Title: [Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide].

Journal: Nederlands tijdschrift voor geneeskunde 20090117

Title: Punding in patients on dopamine agonists for restless leg syndrome.

Journal: Movement disorders : official journal of the Movement Disorder Society 20090115

Title: Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.

Journal: Movement disorders : official journal of the Movement Disorder Society 20090115

Title: Valvular heart disease in patients with Parkinson's disease treated with pergolide, levodopa or both.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20090101

Title: [Pleural effusion caused by pergolide].

Journal: Archivos de bronconeumologia 20090101

Title: Cardiac surgery in a patient with retroperitoneal fibrosis and heart valvulopathy, both due to pergolide medication for Parkinson's disease.

Journal: Journal of cardiothoracic surgery 20090101

Title: Valvular heart disease associated with taking low-dose pergolide for restless legs syndrome.

Journal: European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 20081101

Title: Pergolide and valvular heart disease: the lower the better?

Journal: European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 20081101

Title: Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.

Journal: Journal of neurology 20081001

Title: A ligand-based approach to mining the chemogenomic space of drugs.

Journal: Combinatorial chemistry & high throughput screening 20080901

Title: Pergolide increases the efficacy of cathodal direct current stimulation to reduce the amplitude of laser-evoked potentials in humans.

Journal: Journal of pain and symptom management 20080701

Title: Valvular heart disease in patients with Parkinson's disease treated with pergolide. Course following treatment modifications.

Journal: Journal of neurology 20080701

Title: Rheumatoid arthritis accompanied by Parkinson disease.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20080601

Title: The frequency of cardiac valvular regurgitation in Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society 20080515

Title: Pergolide associated cardiac valvulopathy based on Ontario administrative data.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20080501

Title: The variability of levodopa response in Parkinson's disease: is sensitization reversible?

Journal: Movement disorders : official journal of the Movement Disorder Society 20080430

Title: Sclerosing mesenteritis: an ergot-related complication of pergolide therapy in Parkinson's disease?

Journal: Movement disorders : official journal of the Movement Disorder Society 20080430

Title: Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment.

Journal: Journal of neurochemistry 20080301

Title: Characterization of the molecular fragment that is responsible for agonism of pergolide at serotonin 5-Hydroxytryptamine2B and 5-Hydroxytryptamine2A receptors.

Journal: The Journal of pharmacology and experimental therapeutics 20080301

Title: Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice.

Journal: Journal of sleep research 20080301

Title: [Isolated pulmonary hypertension and pergolide].

Journal: Revue neurologique 20080301

Title: Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.

Journal: Journal of neuroscience research 20080215

Title: Pergolide protects CA1 neurons from apoptosis in a gerbil model of global cerebral ischemia.

Journal: Neurological research 20080201

Title: Burden of cardiovascular diseases in elderly with Parkinson's disease who start a dopamine agonist agent.

Journal: Journal of the American Geriatrics Society 20080201

Title: [Low dose pergolide induced systemic edema and pleural effusion in a patient with Parkinson's disease].

Journal: Rinsho shinkeigaku = Clinical neurology 20080201

Title: Dopaminergic potentiation of rTMS-induced motor cortex inhibition.

Journal: Biological psychiatry 20080115

Title: Pramipexole safely replaces ergot dopamine agonists with either rapid or slow switching.

Journal: The Journal of international medical research 20080101

Title: Conversion from dopamine agonists to cabergoline: an open-label trial in 128 patients with advanced Parkinson disease.

Journal: Clinical neuropharmacology 20080101

Title: [Cardiac valvulopathy and dopamine agonist].

Journal: Neurologia (Barcelona, Spain) 20071201

Title: Heart valve regurgitation, pergolide use, and parkinson disease: an observational study and meta-analysis.

Journal: Archives of neurology 20071201

Title: Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study.

Journal: Movement disorders : official journal of the Movement Disorder Society 20071115

Title: Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects.

Journal: Psychopharmacology 20071101

Title: Low incidence of restrictive valvulopathy in patients with Parkinson's disease on moderate dose of pergolide.

Journal: Journal of neurology 20071101

Title: Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists.

Journal: Movement disorders : official journal of the Movement Disorder Society 20071015

Title: Dopaminergic agonists: possible neurorescue drugs endowed with independent and synergistic multisites of action.

Journal: Neurochemical research 20071001

Title: Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners.

Journal: Clinical linguistics & phonetics 20071001

Title: Dopamine treatment in brain-dead rats mediates anti-inflammatory effects: the role of hemodynamic stabilization and D-receptor stimulation.

Journal: Transplant international : official journal of the European Society for Organ Transplantation 20070901

Title: In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology.

Journal: European heart journal 20070901

Title: Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease.

Journal: The Lancet. Neurology 20070901

Title: Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum.

Journal: Journal of neurochemistry 20070801

Title: Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study.

Journal: Neurology 20070703

Title: Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20070701

Title: FDA-CVM works to address concerns about pergolide supplies.

Journal: Journal of the American Veterinary Medical Association 20070701

Title: Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal.

Journal: European journal of pharmacology 20070622

Title: Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists.

Journal: European journal of neurology 20070601

Title: Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for alpha-synuclein fibrils in vitro.

Journal: Journal of neuroscience research 20070515

Title: Reversal of cocaine sensitization-induced behavioral sensitization normalizes GAD67 and GABAA receptor alpha2 subunit expression, and PKC zeta activity.

Journal: Biochemical and biophysical research communications 20070511

Title: Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease.

Journal: Journal of neurology, neurosurgery, and psychiatry 20070501

Title: Assessment of valvulopathy in Parkinson's disease patients on pergolide and/or cabergoline.

Journal: Clinical neurology and neurosurgery 20070501

Title: Effects of pergolide on severe sleep bruxism in a patient experiencing oral implant failure.

Journal: Journal of oral rehabilitation 20070501

Title: Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?

Journal: Neurology 20070424

Title: Dopamine agonists and valvular heart disease.

Journal: The New England journal of medicine 20070419

Title: Dopamine agonists and valvular heart disease.

Journal: The New England journal of medicine 20070419

Title: Identification of amino acid determinants of dopamine 2 receptor synthetic agonist function.

Journal: The Journal of pharmacology and experimental therapeutics 20070401

Title: Parkinson's drugs linked to heart valve trouble.

Journal: Harvard heart letter : from Harvard Medical School 20070401

Title: [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].

Journal: Rinsho shinkeigaku = Clinical neurology 20070401

Title: Improved photostability indicating ion-pair chromatography method for pergolide analysis in tablets and in the presence of cyclodextrins.

Journal: Journal of pharmaceutical and biomedical analysis 20070312

Title: Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.

Journal: Archives of neurology 20070301

Title: Treatment of juvenile Parkinson disease and the recurrent emergence of pathologic gambling.

Journal: Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 20070301

Title: Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070201

Title: Quetiapine in a case with Parkinson disease and pathological gambling.

Journal: Journal of clinical psychopharmacology 20070201

Title: Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20070130

Title: Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.

Journal: Movement disorders : official journal of the Movement Disorder Society 20070115

Title: Drugs and valvular heart disease.

Journal: The New England journal of medicine 20070104

Title: Dopamine agonists and the risk of cardiac-valve regurgitation.

Journal: The New England journal of medicine 20070104

Title: Valvular heart disease and the use of dopamine agonists for Parkinson's disease.

Journal: The New England journal of medicine 20070104

Title: About the anti-Parkinson equivalency of levodopa and dopamine agonists.

Journal: Clinical neuropharmacology 20070101

Title: Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.

Journal: Drug safety 20070101

Title: [Dopamine agonists in the treatment of motor complications in advanced Parkinson's disease].

Journal: Neurologia i neurochirurgia polska 20070101

Title: [Reactivity and communication of Health Authorities toward health professionals: a public health priority].

Journal: Therapie 20070101

Title: Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia.

Journal: Progress in neuro-psychopharmacology & biological psychiatry 20061230

Title: Paraphilic behaviours in a parkinsonian patient with hedonistic homeostatic dysregulation.

Journal: The international journal of neuropsychopharmacology 20061201

Title: Tonic dopaminergic stimulation impairs associative learning in healthy subjects.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20061101

Title: Medical hazards of the internet: gambling in Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society 20061001

Title: Dopaminergic modulation of semantic priming in healthy volunteers.

Journal: Biological psychiatry 20060915

Title: Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans.

Journal: Psychopharmacology 20060901

Title: Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.

Journal: Movement disorders : official journal of the Movement Disorder Society 20060801

Title: A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.

Journal: Clinical therapeutics 20060801

Title: Pergolide-induced ergotism.

Journal: Neurology 20060711

Title: Sensorimotor effects of pergolide, a dopamine agonist, in healthy subjects: a lateralized readiness potential study.

Journal: Psychopharmacology 20060701

Title: Association of dopamine agonist use with impulse control disorders in Parkinson disease.

Journal: Archives of neurology 20060701

Title: Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement.

Journal: Parkinsonism & related disorders 20060601

Title: Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments.

Journal: Journal of pharmacokinetics and pharmacodynamics 20060601

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia.

Journal: Pharmacopsychiatry 20060501

Title: A functional magnetic resonance imaging study of the effects of pergolide, a dopamine receptor agonist, on component processes of working memory.

Journal: Neuroscience 20060428

Title: [Ergoline-induced retroperitoneal fibrosis].

Journal: Ugeskrift for laeger 20060424

Title: Valvular heart disease in a patient with Parkinson's disease treated with a low daily dose and a low cumulative dose of pergolide.

Journal: Movement disorders : official journal of the Movement Disorder Society 20060401

Title: Hiccups associated with dopamine agonists in Parkinson disease.

Journal: Neurology 20060314

Title: Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study.

Journal: Movement disorders : official journal of the Movement Disorder Society 20060301

Title: Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex.

Journal: The European journal of neuroscience 20060301

Title: [Ergoline-induced retroperitoneal fibrosis].

Journal: Ugeskrift for laeger 20060227

Title: PI3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity.

Journal: Biochemical and biophysical research communications 20060224

Title: Cardiac valvulopathy associated with pergolide use.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20060201

Title: Valvular heart disease in pergolide-treated Parkinson's disease.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20060201

Title: Pergolide-associated valvular heart disease.

Journal: Comprehensive therapy 20060101

Title: The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial.

Journal: Parkinsonism & related disorders 20051201

Title: Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist.

Journal: The Journal of pharmacology and experimental therapeutics 20051201

Title: [Effects of low-dose pergolide therapy on cardiac valves in patients with Parkinson's disease].

Journal: Journal of cardiology 20051201

Title: Combined D1/D2 receptor stimulation under conditions of dopamine depletion impairs spatial working memory performance in humans.

Journal: Psychopharmacology 20051001

Title: The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values.

Journal: Psychopharmacology 20051001

Title: Pergolide is an inhibitor of voltage-gated potassium channels, including Kv1.5, and causes pulmonary vasoconstriction.

Journal: Circulation 20050906

Title: Normalization of voice in spasmodic dysphonia during transient global amnesia.

Journal: Movement disorders : official journal of the Movement Disorder Society 20050901

Title: High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.

Journal: Parkinsonism & related disorders 20050901

Title: Response to Clinical Corners case (Sleep Medicine 6/2: 83-4): Pregnancy associated with daytime sleepiness and nighttime restlessness.

Journal: Sleep medicine 20050901

Title: Reversible weight gain and prolactin levels--long-term follow-up in childhood.

Journal: Journal of pediatric endocrinology & metabolism : JPEM 20050901

Title: Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease.

Journal: Archives of neurology 20050801

Title: Valvular heart disease in patients taking pergolide.

Journal: Mayo Clinic proceedings 20050801

Title: [Pergolide associated valvulopathy: critical analysis of the literature and practical recommendations].

Journal: Revue neurologique 20050701

Title: Effective adjunctive use of pergolide with quetiapine for cognitive impairment and negative symptoms in schizophrenia.

Journal: Journal of clinical psychopharmacology 20050601

Title: Pergolide improvement in neuroleptic-resistant Tourette cases: various mechanisms causing tics.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20050601

Title: Levodopa in the treatment of Parkinson's disease: current controversies.

Journal: Movement disorders : official journal of the Movement Disorder Society 20050501

Title: Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.

Journal: Movement disorders : official journal of the Movement Disorder Society 20050501

Title: Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy.

Journal: Neurology 20050426

Title: [Severe insuffiency of the aortic and tricuspidal valves associated with pergolide use].

Journal: Nederlands tijdschrift voor geneeskunde 20050416

Title: Diagnosis and management of pergolide-induced fibrosis.

Journal: Movement disorders : official journal of the Movement Disorder Society 20050401

Title: Differential dopaminergic modulation of executive control in healthy subjects.

Journal: Psychopharmacology 20050401

Title: [Optimum dosage of pergolide in patients with Parkinson's disease].

Journal: Rinsho shinkeigaku = Clinical neurology 20050401

Title: Trial of subtherapeutic pergolide in de novo Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society 20050301

Title: Sleep attacks in patients receiving dopamine-receptor agonists.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050301

Title: Pergolide effect on cognitive functions in early-mild Parkinson's disease.

Journal: Journal of neural transmission (Vienna, Austria : 1996) 20050201

Title: Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243.

Journal: Behavioural brain research 20050130

Title: A randomly assigned double-blind cross-over study examining the relative anti-parkinsonian tremor effects of pramipexole and pergolide.

Journal: European journal of neurology 20050101

Title: [Organ changes induced by ergot derivative dopamine agonist drugs: time to change treatment guidelines in Parkinson's disease?].

Journal: Casopis lekaru ceskych 20050101

Title: Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease.

Journal: Clinical neuropharmacology 20050101

Title: High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label study.

Journal: Archives of gerontology and geriatrics 20050101

Title: Use of dopamine agonist pergolide in outpatient treatment of cocaine dependence.

Journal: Substance use & misuse 20050101

Title: Dopamine agonist pergolide prevents levodopa-induced quinoprotein formation in parkinsonian striatum and shows quenching effects on dopamine-semiquinone generated in vitro.

Journal: Clinical neuropharmacology 20050101

Title: Effects of donepezil on compulsive hypersexual behavior in Parkinson disease: a single case study.

Journal: American journal of therapeutics 20050101

Title: Refractory generalized edema: an infrequent complication of long-term pergolide treatment for Parkinson disease.

Journal: Clinical neuropharmacology 20050101

Title: Reversible Pisa syndrome in Parkinson's disease during treatment with pergolide: a case report.

Journal: Clinical neuropharmacology 20050101

Title: Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease.

Journal: Pharmacological reports : PR 20050101

Title: Pharmacologic resistance in prolactinoma patients.

Journal: Pituitary 20050101

Title: Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.

Journal: Pituitary 20050101

Title: Fibrotic valvular heart disease is not related to chemical class but to biological function: 5-HT2B receptor activation plays crucial role.

Journal: Movement disorders : official journal of the Movement Disorder Society 20041201

Title: Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.

Journal: Movement disorders : official journal of the Movement Disorder Society 20041201

Title: Dopaminagonists and fibrotic valvular heart disease: further considerations.

Journal: Movement disorders : official journal of the Movement Disorder Society 20041201

Title: Neuroprotection by pergolide against levodopa-induced cytotoxicity of neural stem cells.

Journal: Neurochemical research 20041201

Title: [Special issue: the reports presented during the 5th Parkinson's Physicians' Symposium].

Journal: Praxis 20041103

Title: [Are there innovations in the treatment of Parkinson's disease?].

Journal: Praxis 20041103

Title: Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.

Journal: Movement disorders : official journal of the Movement Disorder Society 20041101

Title: Retroperitoneal fibrosis caused by pergolide in a patient with Parkinson's disease.

Journal: The Netherlands journal of medicine 20041101

Title: Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.

Journal: The Cochrane database of systematic reviews 20041018

Title: Cardiopulmonary complications of ergot-derivative dopamine agonists.

Journal: The Journal of clinical psychiatry 20041001

Title: Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat.

Journal: Brain research 20040813

Title: Equine cushing-like syndrome: diagnosis and therapy in two cases.

Journal: Veterinary research communications 20040801

Title: Pergolide use in Parkinson disease is associated with cardiac valve regurgitation.

Journal: Neurology 20040727

Title: Pergolide mesylate can improve sexual dysfunction in patients with Parkinson's disease: the results of an open, prospective, 6-month follow-up.

Journal: European journal of neurology 20040701

Title: Pergolide in Parkinson's disease: time for a change?

Journal: Lancet (London, England) 20040605

Title: Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson's disease.

Journal: Journal of neural transmission (Vienna, Austria : 1996) 20040601

Title: New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance.

Journal: Movement disorders : official journal of the Movement Disorder Society 20040601

Title: Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.

Journal: Movement disorders : official journal of the Movement Disorder Society 20040601

Title: Diagnosis and management of pergolide-induced fibrosis.

Journal: Movement disorders : official journal of the Movement Disorder Society 20040601

Title: Extensive fibromuscular dysplasia in a patient with Parkinson disease.

Journal: The American journal of the medical sciences 20040601

Title: Rapid onset of pergolide-induced pulmonary fibrosis in a patient with corticobasal degeneration.

Journal: Hospital medicine (London, England : 1998) 20040601

Title: A novel mechanism for pergolide-induced neuroprotection: inhibition of NF-kappaB nuclear translocation.

Journal: Biochemical pharmacology 20040501

Title: Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study.

Journal: Neurology 20040427

Title: Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease.

Journal: Lancet (London, England) 20040410

Title: Effects of pergolide on nocturia in Parkinson's disease: three female cases selected from over 400 patients.

Journal: Parkinsonism & related disorders 20040301

Title: Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.

Journal: Archives of neurology 20040101

Title: [A comparative study of efficacy of dopamine receptors agonists and catechol-O-methyltransferase in the treatment of late stages of Parkinson's disease].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20040101

Title: [Pergolide treatment and cardiac valve pathology: the continuing saga of ergotamine-induced fibrosis].

Journal: Revue neurologique 20040101

Title: Pergolide, terguride and N,N'-spacer-linked oligomers of both interact with 5-HT2A receptors of rat tail artery.

Journal: Physiological research 20040101

Title: Plasma homocysteine levels in pergolide-treated Parkinson disease patients.

Journal: Clinical neuropharmacology 20040101

Title: Influence of the therapy with pergolide mesylate plus L-DOPA and with L-DOPA alone on serum cGMP level in PD patients.

Journal: Polish journal of pharmacology 20040101

Title: Pergolide mesylate, a dopaminergic receptor agonist, applied with L-DOPA enhances serum antioxidant enzyme activity in Parkinson disease.

Journal: Clinical neuropharmacology 20040101

Title: Valvular health disease with pergolide.

Journal: Prescrire international 20031201

Title: The pharmacokinetics of pergolide in Parkinson's disease.

Journal: Current opinion in neurology 20031201

Title: Comparing dopamine agonists in Parkinson's disease.

Journal: Current opinion in neurology 20031201

Title: Appropriate dosing of pergolide in monotherapy and adjunctive therapy in Parkinson's disease.

Journal: Current opinion in neurology 20031201

Title: Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on Parkinsonian tremor.

Journal: Movement disorders : official journal of the Movement Disorder Society 20031101

Title: [Effects of D1 and D2 dopamine receptor agonists and antagonists on cerebral ischemia/reperfusion injury].

Journal: Sheng li xue bao : [Acta physiologica Sinica] 20031025

Title: L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment.

Journal: Neurology 20031014

Title: Pergolide mesylate form II.

Journal: Acta crystallographica. Section C, Crystal structure communications 20031001

Title: Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide.

Journal: Neurology 20030923

Title: [Tardive dyskinesia: pergolid, a possible therapeutic option].

Journal: Psychiatrische Praxis 20030901

Title: Pathological gambling associated with dopamine agonist therapy in Parkinson's disease.

Journal: Neurology 20030812

Title: Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.

Journal: European journal of neurology 20030701

Title: High-sensitivity quantitation of cabergoline and pergolide using a triple-quadrupole mass spectrometer with enhanced mass-resolution capabilities.

Journal: Journal of mass spectrometry : JMS 20030701

Title: Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes.

Journal: Life sciences 20030620

Title: Dopamine agonist therapy for hyperprolactinemia.

Journal: Clinical obstetrics and gynecology 20030601

Title: Additional insights into pergolide-associated valvular heart disease.

Journal: Mayo Clinic proceedings 20030601

Title: The US Food and Drug Administration's registry of patients with pergolide-associated valvular heart disease.

Journal: Mayo Clinic proceedings 20030601

Title: [Hypersexuality during use of levodopa].

Journal: Nederlands tijdschrift voor geneeskunde 20030517

Title: The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa.

Journal: Age and ageing 20030501

Title: [Gilles de la tourette syndrome: clinical spectrum and management].

Journal: Revista de neurologia 20030401

Title: Neuroendocrine and behavioral responses to dopaminergic agonists in adolescents with alcohol abuse.

Journal: Psychopharmacology 20030301

Title: [(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.

Journal: Journal of neurology, neurosurgery, and psychiatry 20030301

Title: The modulatory effects of dopamine D1 and D2 receptor function on object working memory in humans.

Journal: Journal of psychopharmacology (Oxford, England) 20030301

Title: Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleep.

Journal: Sleep medicine 20030301

Title: Tic reduction with pergolide in a randomized controlled trial in children.

Journal: Neurology 20030225

Title: Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society 20030201

Title: The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action.

Journal: Journal of controlled release : official journal of the Controlled Release Society 20030109

Title: Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030101

Title: Both short- and long-acting D-1/D-2 dopamine agonists induce less dyskinesia than L-DOPA in the MPTP-lesioned common marmoset (Callithrix jacchus).

Journal: Experimental neurology 20030101

Title: Cognitive effects of the dopamine receptor agonist pergolide.

Journal: Neuropsychologia 20030101

Title: Hyperprolactinemia: pathophysiology and management.

Journal: Treatments in endocrinology 20030101

Title: Neuroleptic malignant-like syndrome after rapid switch from bromocriptine to pergolide.

Journal: Parkinsonism & related disorders 20021201

Title: Drug-related valvular heart disease: here we go again: will we do better this time?

Journal: Mayo Clinic proceedings 20021201

Title: Valvular heart disease in patients taking pergolide.

Journal: Mayo Clinic proceedings 20021201

Title: Dopamine agonist monotherapy in Parkinson's disease.

Journal: Lancet (London, England) 20021130

Title: Long term tolerability of high dose ergoline derived dopamine agonist therapy for the treatment of Parkinson's disease.

Journal: Journal of neurology, neurosurgery, and psychiatry 20021101

Title: Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide.

Journal: Equine veterinary journal 20021101

Title: Muscarinic agonist-mediated increases in serum corticosterone levels are abolished in m(2) muscarinic acetylcholine receptor knockout mice.

Journal: The Journal of pharmacology and experimental therapeutics 20021001

Title: [Cutaneous vasculitis during pergolide mesylate treatment].

Journal: La Revue de medecine interne 20020901

Title: The effect of pergolide on cognitive performance of young and middle-aged rats.

Journal: The International journal of neuroscience 20020901

Title: [Pergolide-induced pleural effusion in a patient with juvenile parkinsonism].

Journal: Rinsho shinkeigaku = Clinical neurology 20020801

Title: Pituitary pars intermedia dysfunction: equine Cushing's disease.

Journal: The Veterinary clinics of North America. Equine practice 20020801

Title: Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: characterization and in vitro transport studies.

Journal: Pharmaceutical research 20020701

Title: Pergolide-induced lung disease in patients with Parkinson's disease.

Journal: Respiratory medicine 20020701

Title: [Pergolide: a useful agonist for the treatment of Parkinson disease].

Journal: Revue neurologique 20020701

Title: Dopamine receptor agonists for treating prolactinomas.

Journal: Expert opinion on investigational drugs 20020601

Title: Delayed visual loss following pergolide treatment of a prolactinoma.

Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20020601

Title: [Multiple latency test in a patient with episodes of sleep induced by pergolide].

Journal: Revista de neurologia 20020601

Title: Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist.

Journal: Neuroreport 20020507

Title: Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies.

Journal: Psychopharmacology 20020501

Title: Pergolide protects dopaminergic neurons in primary culture under stress conditions.

Journal: Journal of neural transmission (Vienna, Austria : 1996) 20020501

Title: A new design of a polysomnography-based multi-center treatment study for the restless legs syndrome.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20020401

Title: [The evolution of use of anti-Parkinson drugs in Spain].

Journal: Revista de neurologia 20020401

Title: Antiparkinsonian treatment in pregnancy.

Journal: Movement disorders : official journal of the Movement Disorder Society 20020301

Title: [Multiple system atrophy which had been treated as juvenile Parkinson's disease].

Journal: No to shinkei = Brain and nerve 20020301

Title: Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD.

Journal: Neurology 20020212

Title: Pergolide protects SH-SY5Y cells against neurodegeneration induced by H(2)O(2).

Journal: European journal of pharmacology 20020102

Title: Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster.

Journal: The Journal of pharmacology and experimental therapeutics 20020101

Title: Chronic pericardial constriction linked to the antiparkinsonian dopamine agonist pergolide.

Journal: Postgraduate medical journal 20020101

Title: Pergolide in the treatment of patients with early and advanced Parkinson's disease.

Journal: Clinical neuropharmacology 20020101

Title: Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson's disease.

Journal: Journal of neurology 20020101

Title: Effects of pergolide on blood pressure and tissue injury in DOCA-salt hypertension.

Journal: Blood pressure 20020101

Title: Elastic vesicles: interaction with human skin and drug transport.

Journal: Cellular & molecular biology letters 20020101

Title: DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society 20020101

Title: DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society 20020101

Title: [Use of dopamine agonists in the treatment of Parkinson's disease].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20020101

Title: Pergolide-induced pleuropulmonary fibrosis.

Journal: Clinical neuropharmacology 20020101

Title: Pergolide mesilate may improve fatigue in patients with Parkinson's disease.

Journal: Behavioural neurology 20020101

Title: Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease).

Journal: Journal of veterinary internal medicine 20020101

Title: Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function.

Journal: Pituitary 20020101

Title: Apomorphine, dopamine and phenylethylamine reduce the proportion of phosphorylated insulin receptor substrate 1.

Journal: European journal of pharmacology 20011214

Title: Effects of pergolide on sensorimotor gating of the startle reflex in rats.

Journal: Psychopharmacology 20011101

Title: Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations.

Journal: Movement disorders : official journal of the Movement Disorder Society 20010901

Title: Pleuropulmonary disease due to pergolide use for restless legs syndrome.

Journal: Chest 20010701

Title: Long-term effects of pergolide in the treatment of restless legs syndrome.

Journal: Neurology 20010522

Title: [Parkinson's disease].

Journal: Presse medicale (Paris, France : 1983) 20010303

Title: [Sleep attacks and pergolide mesylate].

Journal: Neurologia (Barcelona, Spain) 20010201

Title: Efficacy and tolerability of dopamine agonists in a parkinsonian population.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010201

Title: Switching from pergolide to pramipexole in patients with Parkinson's disease.

Journal: Journal of neural transmission (Vienna, Austria : 1996) 20010101

Title: Adverse outcomes in a controlled trial of pergolide for cocaine dependence.

Journal: Journal of addictive diseases 20010101

Title: Quick titration of pergolide in cotreatment with domperidone is safe and effective.

Journal: Clinical neuropharmacology 20010101

Title: Are dopamine receptor agonists neuroprotective in Parkinson's disease?

Journal: Drugs & aging 20010101

Title: The effect of a dopamine agonist on dysarthric speech production: a case study.

Journal: Journal of communication disorders 20010101

Title: Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan.

Journal: PharmacoEconomics 20010101

Title: Cost-effectiveness of pergolide compared to bromocriptine in the treatment of Parkinson's disease: a decision-analytic model.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20010101

Title: Chronic akinetic mutism after mesencephalic-diencephalic infarction: remediated with dopaminergic medications.

Journal: Neurorehabilitation and neural repair 20010101

Title: [Dopaminergic agonists in the treatment of Parkinson's disease].

Journal: Revue medicale de Bruxelles 20001201

Title: A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence.

Journal: Drug and alcohol dependence 20000801

Title: Transverse myelitis associated with restless legs syndrome and periodic movements of sleep responsive to an oral dopaminergic agent but not to intrathecal baclofen.

Journal: Sleep 20000801

Title: Sleep attacks (sleep episodes) with pergolide.

Journal: Lancet (London, England) 20000415

Title: Sleep attacks and Parkinson's disease treatment.

Journal: Lancet (London, England) 20000415

Title: Treatment of Parkinson's disease with ropinirole after pergolide-induced retroperitoneal fibrosis.

Journal: Pharmacotherapy 19991201

Title: Effect of pergolide on restless legs and leg movements in sleep in uremic patients.

Journal: Sleep 19980915

Title: Clozapine for dopaminergic-induced paraphilias in Parkinson's disease.

Journal: Movement disorders : official journal of the Movement Disorder Society 19980501

Title: Cenesthetic hallucinations in a patient with Parkinson's disease.

Journal: Journal of neurology, neurosurgery, and psychiatry 19970701

Title: Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa.

Journal: Journal of neural transmission (Vienna, Austria : 1996) 19970101

Title: High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.

Journal: Movement disorders : official journal of the Movement Disorder Society 19960501

Title: A 'combined' levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.

Journal: Movement disorders : official journal of the Movement Disorder Society 19950901

Title: Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.

Journal: Endocrine regulations 19920301

Title: Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients.

Journal: Annals of neurology 19910801

Title: Hallucinations and confusion after pergolide withdrawal.

Journal: Clinical neuropharmacology 19881201

Title: Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.

Journal: The Journal of pharmacology and experimental therapeutics 19851201

Title: The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease.

Journal: The American journal of the medical sciences 19850901

Title: Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.

Journal: Neurology 19850501

Title: Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.

Journal: European journal of pharmacology 19840713

Title: Erythromelalgia following pergolide administration.

Journal: The British journal of dermatology 19840701

Title: Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.

Journal: The Journal of pharmacology and experimental therapeutics 19840301

Title: Dopa dose-dependent sexual deviation.

Journal: The British journal of psychiatry : the journal of mental science 19830301

Title: Anwesenheit: psychopathology and clinical associations.

Journal: The British journal of psychiatry : the journal of mental science 19821201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:66104-23-2 Molecular Formula|66104-23-2 MDL|66104-23-2 SMILES|66104-23-2 Pergolide mesylate salt